Cargando…
High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin
The widely reported conflicting effects of progestin on breast cancer suggest that the progesterone receptor (PR) has dual functions depending on the cellular context. Cell models that enable PR to fully express anti-tumoral properties are valuable for the understanding of molecular determinant(s) o...
Autores principales: | Bajalovic, Natasa, Or, Yu Zuan, Woo, Amanda R. E., Lee, Shi Hao, Lin, Valerie C. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405688/ https://www.ncbi.nlm.nih.gov/pubmed/36009407 http://dx.doi.org/10.3390/biomedicines10081860 |
Ejemplares similares
-
Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha
por: Perkins, Meghan S., et al.
Publicado: (2022) -
A Chip for Estrogen Receptor Action: Detection of Biomarkers Released by MCF-7 Cells through Estrogenic and Anti-Estrogenic Effects
por: Gier, Konstanze, et al.
Publicado: (2017) -
Novel Melatonin, Estrogen, and Progesterone Hormone Therapy Demonstrates Anti-Cancer Actions in MCF-7 and MDA-MB-231 Breast Cancer Cells
por: Hasan, Mahmud, et al.
Publicado: (2020) -
Progestin and aromatase inhibitor therapy in recurrent, estrogen/progestin receptor positive uterine carcinosarcoma: A case report
por: Liang, Angela L., et al.
Publicado: (2021) -
WS(2)/Polyethylene Glycol Nanostructures
for Ultra-Efficient MCF-7 Cancer Cell Ablation and Electrothermal
Therapy
por: Meivita, Maria Prisca, et al.
Publicado: (2022)